China, Sept. 28 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical research on molecular probes targeting chemokine receptor 4 (CXCR4)'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133418
Registration Time: 2026/09/26
Type: Interventional study
Primary Sponsor: The First Affiliated Hospital of Guilin Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=345020
Published by HT Digital Content Services with permission from Health Daily Digest....